Recruiting
Phase 2
Phase 3

Cannabidiol

Sponsor:

UCLA

Code:

NCT06333041

Conditions

Sanfilippo Syndrome

Mucopolysaccharidosis III

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Interventions

Epidiolex

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center on 2026-06-25.